116 related articles for article (PubMed ID: 20031357)
1. Tau proteins in the cerebrospinal fluid of patients with subacute sclerosing panencephalitis.
Yuksel D; Yilmaz D; Uyar NY; Senbil N; Gurer Y; Anlar B
Brain Dev; 2010 Jun; 32(6):467-71. PubMed ID: 20031357
[TBL] [Abstract][Full Text] [Related]
2. Increased insulin-like growth factor-1 levels in cerebrospinal fluid of advanced subacute sclerosing panencephalitis patients.
Yılmaz D; Yüksel D; Gökkurt D; Oguz H; Anlar B
Eur J Paediatr Neurol; 2016 Jul; 20(4):611-5. PubMed ID: 27061773
[TBL] [Abstract][Full Text] [Related]
3. Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis.
Aydin OF; Ichiyama T; Anlar B
Brain Dev; 2010 Jun; 32(6):463-6. PubMed ID: 19481385
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid pressures in subacute sclerosing panencephalitis.
Olmez A; Yilmaz D; Tan H; Duman O; Güngör S; Okuyaz C; Anlar B
Brain Dev; 2007 Aug; 29(7):409-12. PubMed ID: 17258414
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid apolipoprotein E levels in subacute sclerosing panencephalitis.
Yüksel D; Ichiyama T; Yilmaz D; Anlar B
Brain Dev; 2012 Apr; 34(4):298-301. PubMed ID: 21788110
[TBL] [Abstract][Full Text] [Related]
6. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea.
Ichiyama T; Siba P; Suarkia D; Reeder J; Takasu T; Miki K; Maeba S; Furukawa S
Cytokine; 2006 Jan; 33(1):17-20. PubMed ID: 16413199
[TBL] [Abstract][Full Text] [Related]
7. CSF neurofilament and soluble TNF receptor 1 levels in subacute sclerosing panencephalitis.
Matsushige T; Ichiyama T; Anlar B; Tohyama J; Nomura K; Yamashita Y; Furukawa S
J Neuroimmunol; 2008 Dec; 205(1-2):155-9. PubMed ID: 18945496
[TBL] [Abstract][Full Text] [Related]
8. Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients.
de Bont JM; Vanderstichele H; Reddingius RE; Pieters R; van Gool SW
Eur J Paediatr Neurol; 2008 Jul; 12(4):334-41. PubMed ID: 17951083
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis.
Ichiyama T; Matsushige T; Siba P; Suarkia D; Takasu T; Miki K; Furukawa S
J Infect; 2008 May; 56(5):376-80. PubMed ID: 18395263
[TBL] [Abstract][Full Text] [Related]
10. Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis.
Saruhan-Direskeneli G; Gürses C; Demirbilek V; Yentür SP; Yilmaz G; Onal E; Yapici Z; Yalçinkaya C; Cokar O; Akman-Demir G; Gökyiğit A
Cytokine; 2005 Oct; 32(2):104-10. PubMed ID: 16226466
[TBL] [Abstract][Full Text] [Related]
11. [Subacute sclerosing panencephalitis cases diagnosed by increased CSF/serum measles antibody indices].
Samlıoğlu P; Unalp A; Gökçay A; Altuğlu I; Oztürk A; Zeytinoğlu A
Mikrobiyol Bul; 2012 Oct; 46(4):716-8. PubMed ID: 23188587
[TBL] [Abstract][Full Text] [Related]
12. Predictors of clinical course of subacute sclerosing panencephalitis: experience at the Children's Hospital, Lahore.
Malik MA; Saeed M; Qureshi AU; Ahmed N; Akram M
J Coll Physicians Surg Pak; 2010 Oct; 20(10):671-4. PubMed ID: 20943110
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of anti-CD9 antibodies in the cerebrospinal fluid of patients with subacute sclerosing panencephalitis.
Shimizu T; Matsuishi T; Iwamoto R; Handa K; Yoshioka H; Kato H; Ueda S; Hara H; Tabira T; Mekada E
J Infect Dis; 2002 May; 185(9):1346-50. PubMed ID: 12001055
[TBL] [Abstract][Full Text] [Related]
14. Pseudotumor cerebri secondary to subacute sclerosing panencephalitis.
Ayçiçek A; Işcan A; Ceçe H
Pediatr Neurol; 2009 May; 40(5):371-6. PubMed ID: 19380074
[TBL] [Abstract][Full Text] [Related]
15. Subacute sclerosing panencephalitis (SSPE) associated with congenital measles infection.
Simşek E; Oztürk A; Yavuz C; Kocabay K
Turk J Pediatr; 2005; 47(1):58-62. PubMed ID: 15884631
[TBL] [Abstract][Full Text] [Related]
16. [Subacute sclerosing panencephalitis (SSPE) as differential diagnosis in severe personality changes and ataxia--case report and literature review].
Wölfle J; Schmidt J; Kreft B; Albert F; Haverkamp F
Klin Padiatr; 1997; 209(3):111-5. PubMed ID: 9244817
[TBL] [Abstract][Full Text] [Related]
17. [Subacute sclerosing panencephalitis: fulminant form].
Grippo J; Cáceres L; Asís A; Grippo T; Ruprecht B; López M
Rev Neurol; 2003 Mar 16-31; 36(6):536-9. PubMed ID: 12652417
[TBL] [Abstract][Full Text] [Related]
18. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
Enders-Ruckle G
Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
20. A new brain specific protein in the cerebrospinal fluid (CSF) of subacute sclerosing panencephalitis (SSPE).
Doutriaux C; Alle-Ando L; Attias J; Clerc M
Biomedicine; 1980 Feb; 33(1):24-6. PubMed ID: 7370384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
